Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Inovio Pharmaceuticals Inc New (INO)
Inovio Pharmaceuticals Inc New (INO) News

INO

Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals Inc New

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INO

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

Date	Time	Source	Headline	Symbol	Company
01/06/2021	9:15PM	TipRanks	Inovio: Advaccine Deal Is a Positive but Not a Game Changer, Analyst Says	NASDAQ:INO	Inovio Pharmaceuticals Inc New
01/06/2021	8:00AM	PR Newswire (US)	INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18	NASDAQ:INO	Inovio Pharmaceuticals Inc New
01/05/2021	4:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INO	Inovio Pharmaceuticals Inc New
01/05/2021	4:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INO	Inovio Pharmaceuticals Inc New
01/04/2021	4:12PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INO	Inovio Pharmaceuticals Inc New
01/04/2021	8:00AM	PR Newswire (US)	INOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vaccine Candidate, INO-4800, in Greater Chi...	NASDAQ:INO	Inovio Pharmaceuticals Inc New
12/25/2020	6:31AM	TipRanks	Inovio Presents Positive Covid-19 Vaccine Trial Data; Top Analyst Says Hold	NASDAQ:INO	Inovio Pharmaceuticals Inc New
12/24/2020	9:14AM	PR Newswire (US)	INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet's EClinicalMedic...	NASDAQ:INO	Inovio Pharmaceuticals Inc New
12/15/2020	8:00AM	PR Newswire (US)	INOVIO to Develop DNA-encoded Monoclonal Antibody (dMAb®) Candidates to Treat COVID-19 with Funding from the Defense Advance...	NASDAQ:INO	Inovio Pharmaceuticals Inc New
12/10/2020	8:00AM	PR Newswire (US)	INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 i...	NASDAQ:INO	Inovio Pharmaceuticals Inc New
12/09/2020	8:00AM	PR Newswire (US)	INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Anal Dysplasia Caused by HPV-16/18	NASDAQ:INO	Inovio Pharmaceuticals Inc New
12/07/2020	8:00AM	PR Newswire (US)	INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prev...	NASDAQ:INO	Inovio Pharmaceuticals Inc New
12/03/2020	8:00AM	PR Newswire (US)	INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition of Kaneka Eurogentec...	NASDAQ:INO	Inovio Pharmaceuticals Inc New
11/23/2020	8:00AM	PR Newswire (US)	INOVIO Announces Dosing of First Subject in Phase 1/2 Clinical Trial for INO-3107, its DNA Medicine to Treat a Rare Disease R...	NASDAQ:INO	Inovio Pharmaceuticals Inc New
11/20/2020	8:00AM	PR Newswire (US)	INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® ...	NASDAQ:INO	Inovio Pharmaceuticals Inc New
11/16/2020	4:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INO	Inovio Pharmaceuticals Inc New
11/16/2020	7:00AM	PR Newswire (US)	INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-48...	NASDAQ:INO	Inovio Pharmaceuticals Inc New
11/12/2020	4:22PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INO	Inovio Pharmaceuticals Inc New
11/09/2020	4:05PM	PR Newswire (US)	INOVIO Reports Third Quarter 2020 Financial Results	NASDAQ:INO	Inovio Pharmaceuticals Inc New
10/26/2020	8:00AM	PR Newswire (US)	INOVIO to Report Third Quarter 2020 Financial Results on November 9, 2020	NASDAQ:INO	Inovio Pharmaceuticals Inc New
09/29/2020	3:42PM	Dow Jones News	Danger Is Approaching for Coronavirus Vaccine Stocks -- Heard on the Street	NASDAQ:INO	Inovio Pharmaceuticals Inc New
09/28/2020	5:29PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INO	Inovio Pharmaceuticals Inc New
09/28/2020	7:00AM	PR Newswire (US)	INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800	NASDAQ:INO	Inovio Pharmaceuticals Inc New
09/09/2020	10:47AM	Dow Jones News	Inovio Shares Up After Adding Thermo Fisher as Manufacturer for Vaccine Candidate	NASDAQ:INO	Inovio Pharmaceuticals Inc New
09/08/2020	8:00AM	PR Newswire (US)	INOVIO Adds Thermo Fisher Scientific To Global Manufacturing Consortium	NASDAQ:INO	Inovio Pharmaceuticals Inc New
09/03/2020	4:49PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INO	Inovio Pharmaceuticals Inc New
09/01/2020	8:00AM	PR Newswire (US)	INOVIO to Present at Upcoming Investor Conferences in September	NASDAQ:INO	Inovio Pharmaceuticals Inc New
08/12/2020	7:00PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INO	Inovio Pharmaceuticals Inc New
08/10/2020	4:05PM	PR Newswire (US)	INOVIO Reports Second Quarter 2020 Financial Results; Provides DNA Medicines Clinical Program Mid-Year Update	NASDAQ:INO	Inovio Pharmaceuticals Inc New
07/31/2020	7:12PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INO	Inovio Pharmaceuticals Inc New

Showing the most relevant articles for your search:NASDAQ:INO

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

Ethema Health (PK)

Asia Broadband (PK)

Northwest Biotherapeutics (QB)

Fannie Mae (QB)

Digital Brand Media and ... (PK)

Brookmount Explorations (PK)

Anavex Life Sciences

RespireRx Pharmaceuticals (PK)

Rennova Health (PK)

Lightwave Logic

SMC Entertainment (PK)

Elite Pharmaceuticals (QB)

Net Savings Link (PK)

Delayed Upgrade Clock